Trident Lifeline Limited

Equities

543616

INE0MKA01014

Pharmaceuticals

Delayed Bombay S.E. 03:46:47 2024-05-21 am EDT 5-day change 1st Jan Change
179.4 INR +6.12% Intraday chart for Trident Lifeline Limited +1.33% -4.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Trident Lifeline's CFO Resigns MT
Trident Lifeline Limited Announces Board and Committee Changes CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Trident Lifeline Commissions Manufacturing Units in Surat, India MT
Trident Lifeline Incorporates Wholly Owned Arm MT
Trident Lifeline Limited Approves the Proposal of Incorporation of A Wholly Owned Subsidiary CI
Trident Lifeline Limited Announces Appointment of Jiteshkumar Ramchandra Varkal as Company Secretary and Compliance Officer CI
Trident Lifeline Limited Announces Resignation of Kunal Amrishbhai Chauhan from the Post of Company Secretary and Compliance Officer CI
Trident Lifeline Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
5,649,460 Equity Shares of Trident Lifeline Limited are subject to a Lock-Up Agreement Ending on 16-OCT-2023. CI
Trident Lifeline Completes Acquisition of 51% Stake in TLL Herbal MT
Trident Lifeline Limited completed the acquisition of TLL Herbal Limited. CI
Trident Lifeline Limited completed the acquisition of 18% stake in Tricorp Industries Limited. CI
Trident Lifeline to Acquire 18% Stake in Indian Chemicals Manufactuer MT
Trident Lifeline Limited agreed to acquire 18% stake in Tricorp Industries Limited for INR 0.18 million. CI
Trident Lifeline Gets Board Nod to Acquire Majority Stake in TLL Herbal MT
Trident Lifeline Limited Announces the Resignation of Mr. Dhavl V Shah as Independent Director CI
Trident Lifeline Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Trident Lifeline Limited agreed to acquire 51% stake in Tll Herbal Limited from existing shareholders for INR 0.51 million. CI
Trident Lifeline Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Trident Lifeline Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Trident Lifeline Raises Stake in TNS Pharma to 51% MT
Trident Lifeline Limited acquired 51% stake in TNS Pharma Private Limited. CI
Trident Lifeline Limited has completed an IPO in the amount of INR 353.4192 million. CI
Chart Trident Lifeline Limited
More charts
Trident Lifeline Limited is an India-based pharmaceutical company, which is engaged in providing of capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. The Company operates through seven geographical segments: India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, Rest of World. The Company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, Non-Steroidal Anti-Inflammatory Drug (NSAIDS).
More about the company
  1. Stock Market
  2. Equities
  3. 543616 Stock
  4. News Trident Lifeline Limited
  5. Trident Lifeline Incorporates Wholly Owned Arm
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW